- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02830620
Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy (CHIMIOKINES)
Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy.
The syndrome of anorexia-cachexie, which accompanies numerous cancers is a major comorbidity which compromises the forecast of these patients. Several cytokines pro-inflammatory as interleukines IL1 ß, IL6 or TNFa participate in the physiopathology of this syndrome at the man and the animal. Besides, it is now established that different neuronal populations, localized in the hypothalamus, are nerve centers of the control of the appetite and the energy homéostasie. However, there is not enough evidence of a direct action of cytokines on these neurones, suggesting the participation of intermediate molecules as chimiokines, inflammatory molecules produced in reaction to an immunological stress by gliales cells and acting directly on the surrounding neurones. The implication of chimiokines in the syndrome of anorexia-cachexie associated with the cancer thus seems very likely Among these, chimiokines " Monocyte Chemoattractant Proteins 1-3 " or MCPs represent obvious candidates because they are produced by multiple tumors. Furthermore, to the mouse, the intellectual expression of MCP1 is correlated in the anorexia led by peripheral injections of a bacterial by-product, the lipopolysaccharide (LPS).
The investigators' main objective is to test at the Man's, in situation of cancer of the pancreas any confused stages, the degree of prédictivité of the chimiokine MCP1 towards the syndrome of anorexia-cachexie associated with the cancer. The investigator also suggest describing: i) the link between rate plasmatique of MCP1 and energy metabolism on one hand, physical composition on the other hand;; ii) the impact of the other chimiokines, particularly those of the family of the MCPs, on the anorexia-cachexie bound to the cancer, iii) the correlation enters their profile of expression plasmatique and the severity of the anorexia, the energy metabolism and the physical composition; iv) the same research on the other inflammatory factors plasmatiques, of nature different from chimiokines; v) the correlation between thin mass and anorexia; vi) the evolution of the chimiokines various and inflammatory factors after surgical treatment or chemotherapy with curative aim in 6 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06000
- CHU de Nice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Group 1 {cancer of the pancreas WITH syndrome of anorexia-cachexie}
Inclusion Criteria:
- Patient to hospitalize in the unit of digestive cancer research.
- Patient ≥ 18 years.
- Patient carrier of an adénocarcinome of the pancreas of novo, any stadium confused, diagnosed by imaging and/or histology.
- Existence of at least one of the criteria following to hold(retain) the diagnosis of cachexie cancer patient: not deliberate loss of weight > in 5 % over the last 6 months OR(WHERE) IMC(CEREBRAL-MOTOR HANDICAPPED) < 20 kg / m ² with a loss of minimum weight > 2 % OR(WHERE) scrawny muscular index appendiculaire respectively < 7,26 kg / m ² at the man and < 5,45 kg / m ² at the woman with a minimal weight loss > 2 %.
- Patient having signed the enlightened consent.
Exclusion Criteria:
- Patient having a tumor other one than the pancreatic adénocarcinome.
- Patient having a second offense of adénocarcinome pancreatic.
- Patient carrier of a pancreatic adénocarcinome in the course of a treatment by chemotherapy.
- Patient having a severe psychiatric comorbidity except TCA who can be responsible for food disorders.
- Patient carrier of an evolutionary inflammatory disease other one than the cancer being able to interfere on the inflammatory status.
Groupe 2 {cancer du pancréas SANS syndrome d'anorexie-cachexie}
Inclusion Criteria:
- Patient to hospitalize in the(unit) of digestive cancer research.
- Patient ≥ 18 years.
- Patient carrier of an adénocarcinome of the pancreas of novo, any stadium confused, diagnosed by imaging and/or histology.
- Patient having signed a enlightened consent.
Exclusion Criteria:
- Patient having a tumor other one than the pancreatic adénocarcinome.
- Patient having a second offense(recurrence) of adénocarcinome pancreatic.
- Patient carrier of a pancreatic adénocarcinome in the course of a treatment by chemotherapy.
- Existence of at least one of the criteria in favour of the diagnosis of cachexie cancer patient: not deliberate loss of weight > in 5 % over the last 6 months OR(WHERE) IMC(CEREBRAL-MOTOR HANDICAPPED) < 20 kg / m ² with a loss of minimum weight > 2 % OR(WHERE) scrawny muscular index appendiculaire respectively < 7,26 kg / m ² at the man and < 5,45 kg / m ² at the woman with a minimal weight loss > 2 %.
- Patient having a severe psychiatric comorbidity except TCA who can be responsible for food disorders.
- Patient carrier of an evolutionary inflammatory disease other one than the cancer being able to interfere on the inflammatory status.
- Patient refusing to participate in the study
- Under guardianship patient or guardianship.
Group 3 {pure food limitation typifies restrictive anorexia nervosa}
Inclusion Criteria:
- Patient seen in consultation in the unit of nutritional support(medium)
- Patient ≥ 18 years.
- Patient carrier of an eating disorder of type pure restrictive anorexia nervosa (according to criterion diagnosis of the WHO)
- Patient having signed a enlightened consent.
Exclusion Criteria:
- Patient having any evolutionary organic pathology source of a decrease of the oral contributions and/or the interference on the inflammatory status, and responsible for a loss of weight
- Patient refusing to participate in the study
- Under guardianship patient or guardianship.
Group 4 {unhurt individual of any appetite-suppressing evolutionary disease and cachectisante}
Inclusion Criteria:
- Patient seen in consultation of hepatogastroenterology
- Patient ≥ 18 years.
- Unhurt patient of any organic or psychic, evolutionary pathology, cachectisante
- Patient having signed a enlightened consent.
Exclusion Criteria:
- Patient refusing to participate in the study
- Under guardianship patient or guardianship.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: groupe1
cancer of the pancreas WITH syndrome of anorexia-cachexie Dosage of chimiokines
|
|
Other: groupe2
cancer of the pancreas WITHOUT syndrome of anorexia-cachexie Dosage of chimiokines
|
|
Other: groupe3
pure food limitation typifies restrictive anorexia nervosa Dosage of chimiokines
|
|
Other: groupe4
unhurt individual of any appetite-suppressing evolutionary disease and cachectisante Dosage of chimiokines
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
chimiokine MCP1 expression
Time Frame: change from baseline to 180 days
|
Study at the Man's, in situation of cancer of the pancreas, diagnosed of novo and any confused stages, the prediction of the chimiokine MCP1 towards the syndrome of anorexia-cachexie associated with the cancer
|
change from baseline to 180 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stéphane SCHNEIDER, Pr, Centre Hospitalier Universitaire de Nice
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-PP-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Umeå UniversityActive, not recruitingAnorexia Nervosa | Anorexia in Adolescence | Anorexia Nervosa, AtypicalSweden
-
Mental Health Services in the Capital Region, DenmarkForeningen Spiseforstyrrelser og SelvskadeRecruitingFamily Relations | Anorexia in Adolescence | Anorexia in ChildrenDenmark
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
Rosemary Claire RodenChildren's Miracle NetworkEnrolling by invitationBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
Wageningen UniversityDutch Dairy Organization (NZO)CompletedAnorexia of AgeingNetherlands
-
University Hospital, Basel, SwitzerlandUniversity of ZurichRecruitingAnorexia Nervosa | Anorexia Nervosa Restricting TypeSwitzerland
-
University of California, San DiegoRecruitingAnorexia Nervosa | Atypical Anorexia NervosaUnited States
-
ARCIM Institute Academic Research in Complementary...Filderklinik, Filderstadt, GermanyCompleted
Clinical Trials on Dosage of chimiokines
-
Universidad Autonoma de MadridUnknown
-
Stochastic Research Technologies LLCIndira IVF, IndiaRecruiting
-
University of South CarolinaCompletedConditionUnited States
-
Université Victor Segalen Bordeaux 2CompletedVentilated-acquired PneumoniaFrance
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Jiangsu Province Centers for Disease Control and...RecruitingCOVID-19 | Pulmonary TuberculosisChina
-
University Of PerugiaRecruiting
-
Hospices Civils de LyonRecruiting
-
Sinovac Biotech Co., LtdCompleted
-
TheranexusCompletedParkinson DiseaseUnited States, France, Czechia, Germany, Hungary